CS logo
small CS logo
Seattle Women's

Seattle, Washington, United States
Women's health clinic in Seattle, Washington
3216 NE 45th Pl Suite 100, Seattle, WA 98105

About Seattle Women's


"Seattle Clinical Research Center (SCRC) is a dedicated clinical trial investigative site. SCRC has successfully executed hundreds of multi-specialty Phase I-IV medical device and biopharma clinical trials since 1991 and has a particular expertise in women’s health-related drugs and medical devices as well as migraine and vaccine studies."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Seattle Women's


During the past decade, Seattle Women's conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Seattle Women's" #1 collaborator was "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Seattle Women's


According to Clinical.Site data, the most researched conditions in "Seattle Women's" are "Migraine" (2 trials), "Atrophic Vaginitis" (1 trials), "Cardiovascular Disease" (1 trials), "High Cardiovascular Risk" (1 trials) and "Migraine With Aura" (1 trials). Many other conditions were trialed in "Seattle Women's" in a lesser frequency.

Clinical Trials Intervention Types at Seattle Women's


Most popular intervention types in "Seattle Women's" are "Drug" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Dihydroergotamine" (1 trials), "IZN-6NVS Cream" (1 trials), "Lorcaserin hydrochloride" (1 trials) and "Rimegepant" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Seattle Women's


The vast majority of trials in "Seattle Women's" are 3 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Seattle Women's


Currently, there are NaN active trials in "Seattle Women's". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Seattle Women's, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Seattle Women's, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".